Introduction: Vascular diseases are among the most widespread diseases in the wrold. Among them, the chronic venous insufficiency (CVI) of the lower limbs represents one of the diseases with higher…
Introduction/Definitions: Chronic pain includes neuropathic pain (e.g., post-surgical and post-herpetic neuralgia), chronic inflammatory pain (e.g., arthritis), and pain of unknown origin (e.g., fibromyalgia). Neuropathic pain is distinguished from nociceptive pain. Pain involving a nociceptive mechanism…
Introduction: The FDA has approved two types of medications for the maangement of Alzheimer's disease: cholinesterase inhibitors and the NMDA-type glutamate receptor inhibitor memantine. These therapies serve to alleviate cognitive…
Ypatent® provides strategic patent services for innovators, startups, and companies nationwide. Representation includes biotechnology, pharmaceutical, and general patent prosecution. For inquiries or to discuss a potential matter, contact: Telephone:(813) 419-2296 …
Patent Services Offered: Strategic patent portfolio development Biotechnology and pharmaceutical patent prosecution Freedom-to-operate and clearance analysis Patent due diligence for transactions and investment Patent validity and infringement analysis Contact Ypatent®…
Ypatent® provides strategic patent services for innovators, startups, and companies nationwide. Representation includes biotechnology, pharmaceutical, and general patent prosecution. For inquiries or to discuss a potential matter, contact: Telephone:(813) 419-2296 …
Author Biography: is a patent attorney and former patent examiner with the United States Patent and Trademark Office. Previous to his work as a patent examiner, James was in house counsel…
The pipeline of follow-on (biosimilar) products in developmetn includes nearly 800 biosimilars. See Biosimilarspipeline Guidance for Industry: Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product, May…
Guidance for industry Expedited Programs for Serious Conditions – Drugs and Biologics (May 2014) The FDA has several programs which are intended to facilitate and expedite development and review of…